Chemotherapy-Induced Cardiotoxicity in Adolescent After Heart Transplant: Do Not Forget the Right Ventricle.
Diana Salas-MeraLucía Deiros-BronteÁngela Uceda-GalianoYasmina Mozo-Del CastilloLuis García-GueretaFederico Gutiérrez-LarrayaPublished in: Pediatric cardiology (2019)
The evaluation of oncologic patients at risk of chemotherapy-induced cardiotoxicity usually focuses on left ventricular function. However, recent studies have demonstrated that right ventricle impairment often coexists (and in some cases precedes) left-side affectation. We present the case of a 19-year-old heart transplant recipient who developed severe right ventricular dysfunction secondary to treatment of an abdominal lymphoma.
Keyphrases
- chemotherapy induced
- heart failure
- left ventricular
- mitral valve
- pulmonary artery
- pulmonary hypertension
- young adults
- atrial fibrillation
- mental health
- diffuse large b cell lymphoma
- prostate cancer
- left atrial
- cardiac resynchronization therapy
- rectal cancer
- coronary artery disease
- case control
- radical prostatectomy
- acute coronary syndrome
- coronary artery
- replacement therapy
- aortic valve